Related Experiment Video
Updated: Aug 11, 2026

Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies
Published on: September 19, 2025
Sprouty and cancer: the first terms report
Ting Ling Lo1, Chee Wai Fong, Permeen Yusoff
1Signal Transduction laboratory, Institute of Molecular and Cell Biology, 61 Biopolis Drive, #6-01, Proteos, Singapore, 138673.
Abstract:
The Ras/Erk signaling pathway has a central role in development of multi-cellular organisms as well as in signal transmission in the mature individual. Recently, a family of genes, designated Sprouty, induced by the Ras/Erk pathway was found to specify proteins that inhibited the upstream pathway. Being in a position that is likely to control well-characterized oncogene products suggested that the expression levels of the Sprouty genes may be relevant in human carcinogenesis. Early data on the deregulation of Sprouty expression in breast, prostate and liver cancers is discussed along with the notion that some of them might have potential as tumour markers or that the derived proteins may act as tumour suppressors.
Insights
Sprouty genes, induced by the Ras/Erk pathway, inhibit this signaling. Deregulation of Sprouty expression in cancers suggests potential roles as tumor markers or suppressors in carcinogenesis.
Area of Science:
- Molecular biology
- Cell signaling
- Oncology
Background:
- The Ras/Erk pathway is crucial for multicellular organism development and mature cell signaling.
- Sprouty genes encode proteins that negatively regulate the upstream Ras/Erk pathway.
- Sprouty gene products are positioned to influence oncogene activity.
Purpose of the Study:
- To investigate the relevance of Sprouty gene expression levels in human carcinogenesis.
- To explore the potential of Sprouty genes as tumor markers or tumor suppressors.
Main Methods:
- Analysis of Sprouty gene expression in various human cancers.
- Review of existing data on Sprouty deregulation in cancer.
Main Results:
- Early data indicates deregulation of Sprouty expression in breast, prostate, and liver cancers.
- Some Sprouty genes show potential as biomarkers for cancer detection.
- Sprouty-derived proteins may function as tumor suppressors.
Conclusions:
- Sprouty gene expression is altered in several human cancers, highlighting their role in carcinogenesis.
- Sprouty genes and their protein products represent potential targets for cancer diagnostics and therapeutics.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

